Development of Malignant Melanoma after Levodopa Therapy for Parkinson's Disease, Report of Case & Review
Am J Med 79:119-121, Kochar,A.S., 1985
Levodopa & Melanoma:Three Cases & Review of Literature
JNNP 48:585-588, Rampen,F.H.J., 1985
L-Dopa-Induced Respiratory Disturbance in Parkinson's Disease Suppressed by Tiapride
Neurol 35:235-237, DeKeyser,J.,et al, 1985
Fatal Hyperpyrexia After Withdrawal of Levodopa
Neurol 34:249-251, Sechi,G.P.,et al, 1984
Response Variations in the Treatment of Parkinson's Disease
Neurol 34:1507-1509, deJong,G.J.,et al, 1984
Pathologic Laughing & Crying Treated with Levodopa
Arch Neurol 41:1095-1096, Udaka,F.,et al, 1984
Chronic Low-Dose Levodopa Therapy in Parkinson's Disease:An Argument for Delaying Levodopa Therapy
Neurol 34:991-996, Rajput,A.H.,et al, 1984
Alternate Day Levodopa Therapy in Parkinsonism
Neurol 32:324-326, Koller,W.C., 1982
Meige's Syndrome During Long-term Dopaminergic Therapy in Parkinson's Disease
Arch Neurol 39:451-452, Weiner,W.J.,et al, 1982
Dystonia Musculorum Deformans, Implications of Therapeutic Response to Levodopa & Carbamazepine
Arch Neurol 39:376-377, Garg,B.P., 1982
False-Negative Results With Levodopa For Early Detection Of Huntington's Disease
NEJM 307:561-562, Myers,R.H.,et al, 1982
Drug-induced Asterixis in Parkinson Disease
Neurol 32:553-555, Glantz,R.,et al, 1982
Lisuride Combined with Levodopa in Advanced Parkinson Disease
Neurol 31:1466-1469, Lieberman,A.N.,et al, 1981
Complications of Chronic Levodopa Therapy; Long-term Efficacy of Drug Holiday
Neurol 31:473-476, Koller,W.C.,et al, 1981
Sinemet & the Treatment of Parkinsonism
Ann Int Med 94:364-370, Boshes,B., 1981
Evidence to Support Early Levodopa Therapy in Parkinson Disease
Neurol 31:125-131, Markham,C.H.,et al, 1981
Presymptomatic & Early Detection in Huntington's Disease
Ann Neurol 8:343-347, Klawans,H.L.,et al, 1980
Suppression of"Rubral"Tremor with Levodopa
BMJ 281:1043, Findley,L.J.,et al, 1980
Increased Ratio of Carbidopa to Levodopa in Treatment of Parkinson's Disease
Arch Neurol 37:723-726, Tourtellotte,W.W.,et al, 1980
Increased Dosage of Carbidopa in Patients with Parkinson's Disease Receiving Low Doses of Levodopa
Arch Neurol 37:146-149, Hoehn,M.M., 1980
Levodopa & Presymptomatic Detection of Huntington's Disease-Eight-Year Follow-Up
NEJM 302:1090, Klawans,H.L.,et al, 1980
L-Dopa in Children with Progressive Neurological Disorders
Ann Neurol 7:93, Bugiani,O.,et al, 1980
Analysis of the Clinical Problems in Parkinsonism & the Complications of Long-term Levodopa Therapy
Neurol 29:1253-1260, Lesser,R.P.,et al, 1979
Early-Morning Dystonia-A Late Side Effect of Long-Term Levodopa Therapy
Arch Neurol 36:308-310, Melamed,E., 1979
Dementia in Parkinson Disease
Ann Neurol 6:355-359, Lieberman,A.,et al, 1979
Bromocriptine in Parkinson Disease:Further Studies
Neurol 29:363-369, Lieberman,A.N.,et al, 1979
Parkinsonism With`On-Off'Phenomena-Intravenous Treatment With Levodopa After Major Abdominal Surgery
Arch Neurol 36:32-34, Rosin,A.J.,et al, 1979
L-Dopa Therapy in Parkinson's Disease:Plasma L-Dopa Concentr. Therapeutic Response, & Side Effects
Mayo Clin Proc 46:231-239, Muenter,M.D.,et al, 1979
The L-Dopa On-Off Effect in Parkinson Disease:Treat. by Trans. Drug Withdrawal & Dopamine Receptor Resens
Ann Neurol 4:573-575, Direnfeld,L.,et al, 1978
Comparative Effectiveness of Two Extracerebral DOPA Decarboxylase Inhibitors in Parkinson Disease
Neurol 28:964-968, Lieberman,A.,et al, 1978
Respiratory Dyskinesias:Extrapyramidal Dysfunction & Dyspnea
Ann Int Med 88:327, Weiner,W.J.,et al, 1978
Considerations in the Management of Parkinsonism
Neurol 28:5, Fahn,S.,et al, 1978
Onset & End-of-dose Levodopa-induced Dyskinesias
Arch Neurol 35:261, Lhermitte,F.,et al, 1978
Newer Concepts in Management of Migraine Headaches
J Med Soc N J 74:11, Haidri,N.H.,et al, 1977
Successful Use of Bromocriptine in the treatment of a Patient with Chronic Portasystemic Encephalopathy
NEJM 296:793, Morgan,M.Y.,et al, 1977
Juvenile Parkinsonism Treated with Levodopa
Arch Neurol 34:244, Sachdev,K.K.,et al, 1977
Postural Hypotension:Adrenergic Responsivity, & Levodopa Therapy
Neurol 27:921, Corder,C.N.,et al, 1977
Drug Therapy of Parkinsonism
NEJM 295:814, Bianchine,J.R., 1976
Developments in the Treatment of Parkinsonism
NEJM 295:1433, Calne,D.B., 1976
Drugs that Reduce Efficacy of Levodopa
(Letter) , NEJM 295:153876., Hausner,R., 1976
Studies with Bromocriptine Part 2. Double-blind Comparison with Levodopa in Idiopathic Parkinsonism
Neurol 26:511, Kartzinel,R.,et al, 1976
Treatment of Parkinson's Disease with Bromocriptine
NEJM 295:1400, Lieberman,A.,et al, 1976
Narcolepsy:REM Sleep Suppression by L-Dopa, (Letter)
NEMJ 294:849, Gilbert,J.C.,et al, 1976
Progressive Supranuclear Palsy-Case Study
NEJM 293:346, Richardson,E.P., 1975
Catecholamines & Neurologic Diseases
NEJM 293:274, Moskowitz,M.A.,et al, 1975
Huntington's Chorea-Deficiency of Y-Aminobutynic Acid in Brain
NEJM 288:337, 1973, 289:104, 1973, 292:10295., Perry,T.,et al, 1975
Important Advances in Clinical Medicine
West J Med 123:128, Mosier,J.M.,et al, 1975
Levodopa-Induced Myoclonus
Arch Neurol 32:331-334, Klawans,H.L., 1975
Prolonged Levodopa Therapy
BMJ 383, Feb 1973., , 1973
Start Hesitation-A Side Effect of Long-Term Levodopa Therapy
NEJM 288:1113, Ambani,L.,et al, 1973